Smithkline Beecham Pharmaceuticals(I) Ltd is developing a single shot four-in-one India specific vaccine for dreaded disease like hepatitis B, diptheria, tetnus and whooping cough. The vaccine, which is being developed by Smithkline in conjunction with the Serum Institute of India, is likely to hit the market within two years.